ImmunoACT, backed by Laurus Labs is testing their cancer product
Some oncologists choose not to mention immunotherapy to dying patients, arguing that scientists first must gather rigorous evidence about the benefits and pitfalls
Due to this trial, lesser insulin is needed to control people's blood glucose levels
With promising results, such new weapons are providing hope that cancer can ultimately be defeated